YOLFTbeta
MARX Biotech Co., Ltd.

MARX Biotech Co., Ltd.

7731 · TWO · Healthcare / Pharmaceutical Retailers

4.18TWD+0.06 (+1.46%)

Price History

Full chart

Market Stats

Previous Close4.12
Open4.23
Day Range4.08 – 4.27
52-Week Range3.88 – 10.46
Volume483.72K
Market Cap2.27B
P/E (TTM)69.67
Forward P/E0.00
EPS0.06
Dividend Yield1.38%
Beta0.71
50-Day Avg4.41
200-Day Avg5.29

About

MARX Biotech Co., Ltd. engages in the online retail of men's health food and cosmeceutical products. The company was founded in 2015 and is based in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOYanchao Yang
  • HeadquartersNo. 655, Bannan Road, New Taipei City, Taiwan, Taiwan
  • Websitehttps://marxbiotech.com

Leadership

  • Yanchao YangGM & Director
  • Hao Ping ChenAccounting Supervisor

Financials

Income Statement

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue97.61M110.64M289.93M618.23M635.85M
Growth (%)-+13.35%+162.04%+113.24%+2.85%
Cost of Revenue22.82M26.43M75.33M188.16M241.26M
Gross Profit74.79M84.21M214.59M430.07M394.59M
Gross Margin76.63%76.11%74.02%69.56%62.06%
Operating Expense59.74M83.31M228.93M507.46M534.05M
Operating Income15.05M898.00K-14.34M-77.39M-139.46M
Operating Margin15.42%0.81%-4.94%-12.52%-21.93%
EBITDA19.01M6.97M-10.52M-77.25M91.00M
EBITDA Margin19.48%6.30%-3.63%-12.49%14.31%
Net Income13.78M2.83M-12.92M-96.83M42.92M
Net Income Margin14.12%2.56%-4.46%-15.66%6.75%
R&D-0597.00K25.99M315.00K
R&D as % of Total Revenue-0.00%0.21%4.20%0.05%
Interest Expense49.00K114.00K372.00K2.21M13.69M
Interest Expense % of Total Revenue0.05%0.10%0.13%0.36%2.15%

Balance Sheet

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets91.08M103.19M394.85M731.20M832.72M
Total Liabilities25.46M42.45M101.86M479.95M473.34M
Total Equity65.61M60.73M292.99M251.25M359.38M
Cash16.13M27.73M152.83M74.67M32.77M
Total Debt2.10M13.84M1.88M277.42M-
Net Debt-14.03M-13.89M-150.94M202.75M274.89M

Cash Flow

Currency: TWD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-16.71M11.44M-14.14M-107.18M-148.73M
Investing Cash Flow-48.00K-793.00K-78.09M-286.48M-
Financing Cash Flow29.49M953.00K217.33M315.50M-
Capital Expenditure47.00K696.00K1.74M218.56M14.12M
Free Cash Flow-16.75M10.74M-15.88M-325.74M-162.84M
Dividends Paid-7.35M6.59M--
FCF to OCF100.28%93.92%112.31%303.91%109.49%
Dividend Paid to FCF-68.42%-41.48%--

Key Statistics & Ratios

Market Cap2.27B
Enterprise Value2.43B
Trailing P/E69.67
Forward P/E0.00
Price / Sales3.87
Price / Book7.91
EPS0.06
Book Value0.553
Revenue (TTM)584.74M
Gross Profit (TTM)296.99M
EBITDA-141.90M
Profit Margin5.47%
Operating Margin-17.68%
Return on Equity12.45%
Return on Assets-13.57%
Shares Outstanding541.98M
Shares Float353.06M
Beta0.71
Dividend Yield1.38%
Dividend Rate0.06
Payout Ratio0.00%

Dividends

20261×
0.06Aug 28, 2026

Stock Splits

  • Jul 11, 20242:1